Srikanth Ranganathan, Ph.D.
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
molecular and cellular basis of neurodegenerative diseasesGoogle:
"Srikanth Ranganathan"Mean distance: 19.17 (cluster 11)
Parents
Sign in to add mentorRobert P. Bowser | grad student | 2004 | University of Pittsburgh | |
(Amyotrophic lateral sclerosis molecular mechanisms to diagnostics.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ranganathan S, Bowser R. (2010) p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. The Open Pathology Journal. 4: 11-22 |
Ranganathan S, Nicholl GC, Henry S, et al. (2007) Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 373-9 |
Ranganathan S, Polshyna A, Nicholl G, et al. (2006) Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling. Clinical Proteomics. 2: 91-101 |
Ranganathan S, Williams E, Ganchev P, et al. (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. Journal of Neurochemistry. 95: 1461-71 |
Ranganathan S, Bowser R. (2003) Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. The American Journal of Pathology. 162: 823-35 |
Ranganathan S, Bowser R. (2002) The 12th International Symposium on ALS/MND: scientific advancements in amyotrophic lateral sclerosis. November 18-20, 2001, Oakland, Calif. Brain Pathology (Zurich, Switzerland). 12: 511-4 |
Ranganathan S, Scudiere S, Bowser R. (2001) Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. Journal of Alzheimer's Disease : Jad. 3: 377-385 |